Prior authorization forces doctors to spend 13 hours a week fighting insurers. New federal rules are changing that—here's what you need to know.

Calls Out Genco Board's Five-Month Refusal to Engage on Fully Financed, All-Cash Offer Delivering Certain, Premium Value at Cyclically High Asset ...

The training will take place on June 9 and 10, from 9:30 a.m. to 3 p.m. Priority consideration will be given to applications received by Friday, May 15 at noon. Applications will be accepted on a ...

The opponents argue that the fare cap could limit service as drivers push for higher take-home pay, while drivers and other ...

I read the opinions of Ms. Judy Patterson in the March 19 edition of The Chronicle with mixed emotions — amusement and sadness. She severely criticized Chatham for its lack of an overnight warming ...

Raises Concerns Related to Current Board’s Proposal to Force Tendering Shareholders to Accept Untradeable Tracker Shares Tied to the SpaceX Position Issues Open Letter to Shareholders to Provide the ...

Write: Letters to the editor, Milwaukee Journal Sentinel, 330 E. Kilbourn Avenue, Suite 500, Milwaukee, WI, 53202. Fax: (414)-223-5444. E-mail: jsedit@jrn.com or submit using the form that can be ...

Actor and television host Keke Palmer experienced an unusual moment at the South by Southwest festival when an audience member interrupted a live panel to propose marriage. The incident took place on ...

Select an option below to continue reading this premium story. Already a Honolulu Star-Advertiser subscriber? Log in now to continue reading. The Honolulu Star-Advertiser welcomes all opinions. Want ...

The PGA Tour is exploring a major overhaul of its competitive structure that would compress the season and more than double its premier events, according to an open letter from CEO Brian Rolapp. The ...

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. Maine has a unique opportunity to lead the country in how we support and ...

The US Food and Drug Administration (FDA) sent a warning letter on 10 March to Novo Nordisk at its Plainsboro, NJ, site for a raft of postmarketing adverse drug experience (PADE) violations, including ...